Total Visits

Views
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.75

Total Visits Per Month

August 2020September 2020October 2020November 2020December 2020January 2021February 2021
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.6435053

File Downloads

Views
e9172.full.pdf119

Top country views

Views
United States29
United Kingdom24
Germany10
India4
China3
Mexico2
Spain1
Ireland1
Netherlands1

Top cities views

Views
Ashburn13
Fairfield7
Oakland4
New Delhi3
Beijing1
Boston1
Brookline1
Kunming1
Nanjing1
Santa Clara1